The lived experience of juvenile idiopathic arthritis in young people receiving etanercept

被引:8
|
作者
Livermore, P. [1 ]
Eleftheriou, D. [2 ,3 ,4 ]
Wedderburn, L. R. [2 ,3 ,4 ]
机构
[1] Great Ormond St Hosp Sick Children, Dept Rheumatol, Great Ormond St, London WC1N 3JH, England
[2] UCL, UCLH, Arthritis Res UK Ctr Adolescent Rheumatol, London, England
[3] GOSH, London, England
[4] UCL, Inst Child Hlth, Infect Inflammat & Rheumatol Sect, London, England
来源
PEDIATRIC RHEUMATOLOGY | 2016年 / 14卷
基金
英国医学研究理事会;
关键词
Phenomenology; Paediatric; Juvenile idiopathic arthritis; Etanercept; Qualitative; Expectations; RHEUMATOID-ARTHRITIS;
D O I
10.1186/s12969-016-0083-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: This study explores young people's daily experiences of living with Juvenile Idiopathic Arthritis (JIA) and their thoughts, beliefs and feelings related to the biological drug Etanercept, prescribed as part of their treatment. Methods: An Interpretive Phenomenological approach was used to allow in-depth examinations of the young people's personal accounts of their lived experiences. Data were obtained from 6 young people between the ages of 10-13 years, from one tertiary institution's Paediatric Rheumatology department using audio-taped open-ended interviews. Results: The transcripts yielded seven thousand words of data and two hundred significant statements, which were reduced to five themes; 1) Who understands me, 2) Medicines and injections, 3) Challenges of schooling and friendships, 4) Being different, and 5) Exclusion from sports. There were marked similarities between the young people's statements; however, there were also some striking differences. The theme 'Who understands me' yielded the biggest section of data, but also produced the biggest disparity between the young people. Two patients were very clear that they thought everyone 'understands', whilst two other patients held the belief that 'no one understood'. This paper explores these statements in further detail. Conclusions: The findings from this study can give healthcare professionals novel insight into the likely reactions to-treatment for JIA and, through this, enable them to offer improved support, education and early intervention before these issues become a concern. This study also provides insight into the emotional resilience of young people with JIA.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Psoriasis after treatment of juvenile idiopathic arthritis with etanercept
    Peek, R.
    Scott-Jupp, R.
    Strike, H.
    Clinch, J.
    Ramanan, A. V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) : 1259 - 1259
  • [22] Etanercept treatment for children with refractory juvenile idiopathic arthritis
    Kuo, Ho-Chang
    Yu, Hong-Ren
    Wu, Chih-Chiang
    Chang, Ling-Sai
    Yang, Kuender D.
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (01) : 52 - 56
  • [23] The German etanercept registry for treatment of juvenile idiopathic arthritis
    Horneff, G
    Schmeling, H
    Biedermann, T
    Foeldvari, I
    Ganser, G
    Girschick, HJ
    Hospach, T
    Huppertz, HI
    Keitzer, R
    Küster, RM
    Michels, H
    Moebius, D
    Rogalski, B
    Thon, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1638 - 1644
  • [24] Growth reconstitution in juvenile idiopathic arthritis treated with etanercept
    Schmeling, H
    Seliger, E
    Horneff, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : 779 - 784
  • [25] Etanercept treatment in juvenile idiopathic arthritis: The Polish registry
    Zuber, Zbigniew
    Rutkowska-Sak, Lidia
    Postepski, Jacek
    Dobrzyniecka, Bogna
    Opoka-Winiarska, Violetta
    Kobusinska, Katarzyna
    Gietka, Piotr
    Osinska, Violetta
    Turowska-Heydel, Dorota
    Szczygielska, Izabela
    Kolodziejczyk, Beata
    Swiatek-Baczkowska, Anna
    Gazda, Agnieszka
    Wiland, Piotr
    Tlustochowicz, Witold
    Tuszkiewicz-Misztal, Ewa
    [J]. MEDICAL SCIENCE MONITOR, 2011, 17 (12): : SR35 - SR42
  • [26] Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
    Yokota, Shumpei
    Mori, Masaaki
    Imagawa, Tomoyuki
    Murata, Takuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Takei, Syuji
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (02) : 107 - 113
  • [27] Anaphylaxis to Etanercept in Two Children With Juvenile Idiopathic Arthritis
    Crayne, Courtney B.
    Gerhold, Kerstin
    Cron, Randy Q.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (03) : 129 - 131
  • [28] Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
    Arina Lazareva
    Valda Stanevicha
    Jelizaveta Semjonova
    Ruta Shantere
    Inita Buliņa
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [29] Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis
    Shoop-Worrall, Stephanie J. W.
    Oude Voshaar, Martijn A. H.
    McDonagh, Janet E.
    Van de Laar, Mart A. F. J.
    Wulffraat, Nico
    Thomson, Wendy
    Hyrich, Kimme L.
    Verstappen, Suzanne M. M.
    [J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (07) : 947 - 954
  • [30] FEASIBILITY OF WEARABLE TECHNOLOGIES IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS
    Harbottle, Victoria
    Bennett, Josh
    Duong, Claire
    Foster, Helen
    McErlane, Flora
    [J]. RHEUMATOLOGY, 2018, 57